An Ocean of Hope For MPN Research
Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. We’re posting a story about one of the participants in 23andMe’s MPN Research Initiative...
Read More
Top Genetic Findings of 2012
Take a moment to look back at the ten most interesting and significant genetic findings of 2012 or at least the ones that drew our attention. In the last 12...
Read More
New Discoveries about Rare Blood Disorders from 23andMe
Earlier this year we met our goal of enrolling 1,000 people in a community of people with a collection of rare blood disorders known as myeloproliferative neoplasms, or MPNs. Since...
Read More
Fighting Rare Blood Cancers
Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of...
Read More
SNPwatch: The Jist on JAK2 and Myeloproliferative Neoplasms
Myeloproliferative neoplasms (MPN) are a group of rare blood disorders. First characterized in 1951, it wasn't until 2005 that researchers began to uncover clues about the genetic basis of these diseases. An acquired mutation called V617F in the JAK2 gene is present in many people with MPN, and a growing body of research -- including evidence in 23andMe's MPN research cohort -- suggests that relatively common inherited genetic variants may predispose individuals to V617F-positive MPN.
Read More
Inherited Genetic Variation May Predispose People For Blood Disorder Mutation Later in Life
Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. Sometimes you can have too much of a good thing. Stem cells in your...
Read More